Introductory Chapter: Oral Selinexor, a Selective Inhibitor of Nuclear Export in the Treatment of Patients with Multiple Myeloma Refractory to Proteasome Inhibitors, Immunomodulatory Agents and Monoclonal Antibodies
None
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/75812 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Introductory Chapter: Oral Selinexor, a Selective Inhibitor of Nuclear Export in the Treatment of Patients with Multiple Myeloma Refractory to Proteasome Inhibitors, Immunomodulatory Agents and Monoclonal Antibodies
- Proteasome Inhibitors in the Treatment of Multiple Myeloma
- Emerging Monoclonal Antibodies for the Treatment of Multiple Myeloma
- Thrombosis Associated with Immunomodulatory Agents in Multiple Myeloma
- Proteasome Inhibition and Hematopoietic Stem Cell Transplantation in Multiple Myeloma
- Introduction on Monoclonal Antibodies
- Immunophenotyping in Multiple Myeloma and Others Monoclonal Gammopathies